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Abstract
Purpose of Review: The first aim of this review is to summarize the major evidence-based
psychotherapies for Borderline Personality Disorder (BPD) and the research supporting their use.
The second aim is to explore the evidence for the differential effectiveness of these treatments.
Recent Findings: Four types of specific psychotherapies are identified that show promising
results in at least two randomized controlled trials. In addition, several adjunctive and
minimal/pragmatic interventions are available that are supported by research evidence. Recent
findings highlight the applicability of these treatments across settings and populations and have
begun to show that modified versions of them are also beneficial.
Summary: There is solid evidence that various specific therapies are superior to treatment as
usual in the community for Borderline Personality Disorder. There is no reliable evidence that
any of these specific treatments is more effective than any other, however. In addition, existing
treatments have many elements in common that may be responsible in part for their effects.
Future research will be needed to uncover the influence of various study design factors, patient
characteristics, and treatment parameters on psychotherapy outcome for BPD.

Introduction
Borderline Personality Disorder (BPD) is a relatively severe, impairing, and costly form
of mental illness. [1–3] Studies estimate its prevalence at around 1-2% of the general adult
population and 10-12% of psychiatric outpatients, and the disorder is notably common among
individuals presenting for medical care in other settings. [4] BPD is also probably
underdiagnosed, or misdiagnosed as other disorders, and there remains some degree of stigma
towards individuals with the disorder and pessimism about the prospect of successful treatment
among clinicians, although this situation may be improving. [5–9]
Nonetheless, abundant research now demonstrates the efficacy and effectiveness of
several kinds of psychotherapies for BPD. A recent meta-analysis of randomized controlled trials
suggested small to moderate effect sizes differentiating BPD-specific treatments from treatment
as usual in terms of symptom reduction and amelioration of functioning. [10••] Both Dialectical
Behavior Therapy and specialized psychodynamic psychotherapies were superior to control
groups in this review. There remained a high degree of heterogeneity between the included
studies’ effect sizes, however, showing that the research picture is complicated by other
differences among these trials. Nevertheless, there exists a remarkably diverse array of evidencebased psychotherapies for BPD as compared with many other forms of psychopathology. These
treatments vary in several respects: they come from different theoretical backgrounds and follow
different assumptions as to the core nature of BPD itself; they target different symptoms and use
different techniques; and they are designed with different structures and sometimes for different
settings. Thus, an array of different empirically-supported treatment options is available for this
disorder, despite lingering therapeutic pessimism.

The purpose of this review is to summarize the available evidence-based psychotherapies
for BPD and to highlight major research findings that might serve as guidance for clinicians who
are considering training in one of these modalities or considering referring patients with BPD for
specialty care. I will also emphasize commonalities and differences among the various
treatments. Finally, I will address whether the type of treatment makes a difference in terms of
outcome for the average patient.
Stand-Alone, Specialty Treatments for BPD
The most prominent and widespread evidence-based treatments for BPD were developed
specifically to treat individuals with the disorder. They were spurred by a recognition on the part
of their developers that existing therapies were inadequate for patients with BPD, did not focus
on core symptoms, or used techniques that were unhelpful for this population. Four major standalone, specialty treatments have been developed that have shown positive results in at least two
randomized controlled trials (RCT’s).
Dialectical Behavior Therapy (DBT). Originally developed by Marsha Linehan, DBT is
based on her “biosocial” account of the development of BPD, which holds that the disorder
stems from a combination of a biological tendency to emotional extremes and an invalidating
early environment, producing maladaptive emotion regulation strategies, such as deliberate selfharm. [11] The treatment itself makes use of a broad suite of cognitive, behavioral, and problemsolving interventions, including skills training and in-session coaching, chain analysis,
contingency management, and exposure. These interventions are paired with mindfulness and
other practices from Zen Buddhism, with the ultimate aim of decoupling extreme emotional
experiences from maladaptive behavioral responses. [12] DBT also attends closely to client
motivation as a way to foster engagement in treatment and prevent dropout. The “dialectic” in

the treatment is the back-and-forth between validation – an acceptance of the individual’s
struggles as genuine and understandable – and the need for change; the therapist’s focus on this
dialectic is meant to enhance the patient’s engagement in treatment and prevent dropout.
Traditional DBT includes both individual sessions and group-based skills training modules
focused on mindfulness, interpersonal effectiveness, distress tolerance, and emotion regulation.
[13]
Among the major treatments for BPD, DBT is undoubtedly the therapy with the broadest
evidence base. Since the pioneering randomized controlled trial by Linehan, [14] several
prominent RCT’s of standard outpatient DBT have accumulated. [13,15,16] Adaptations for
inpatient and partial-hospital settings and college counseling centers have also been developed.
[17–20] More recently, a randomized trial investigated whether the major treatment components
of DBT – individual DBT and group-based DBT skills training – are any less effective on their
own than the full DBT package. Results did not support the notion that the combination of
individual DBT and group skills training is necessary. [13] The finding that skills group is
effective on its own is consistent with prior research suggesting that increased skills use can
mediate many of the most important reductions in symptoms that DBT produces, and trials of
DBT skills groups without individual therapy have also resulted in encouraging outcomes. [21–
24] Likewise, the symptom reduction in the individual-only DBT group in this trial is consistent
with a small study showing no differences between individual DBT and individual DBT plus
skills training. [25]
Mentalization-Based Treatment (MBT). MBT is premised on a developmental model of
BPD that is focused on mentalization – the process of understanding one’s own, and others’,
actions in terms of mental states (such as beliefs and intentions). [26] The capacity to mentalize

is thought to develop within the attachment system and to be impaired in individuals with BPD,
resulting in dysfunctional relatedness, self-harm, impulsivity, and the other hallmarks of the
disorder. [27] Accordingly, MBT therapists seek to enhance a patient’s capacity to mentalize, as
well as to identify their affective experience and connect this with how these affects are
represented mentally. The ultimate goal of the treatment is to move the patient toward secure
attachment, thereby enabling effective relationships and better affect and behavior
regulation.[28]
Evidence for the efficacy of MBT comes from several RCT’s. The first of these showed
the superiority of 18 months of MBT delivered in a partial-hospital setting to treatment as usual,
with very large between-group effects. [29] Notably, these gains were maintained at 18-month
and 5-year follow-up, although patients were still underemployed and functioning at a relatively
low level at the last assessment. [30,31] The second of these investigated an outpatient version of
this treatment, with similarly promising results relative to community treatment. [32] A third
RCT suggested that MBT produced similar gains in clinical outcomes to DBT. [33] Tests of
MBT’s effectiveness in ordinary practice settings are also positive. [34,35] Nevertheless, other
results have been somewhat less encouraging; a randomized, partly controlled study of MBT
compared with supportive psychotherapy showed similar outcomes between treatments on all but
one primary outcome measure, [36] and another recent RCT suggested no difference in outcome
between MBT and “specialist treatment as usual.” [37] Differences in treatment intensity
between day-hospital MBT and outpatient MBT may not account for any discrepancies in
efficacy – a recent RCT suggested that these two forms of the treatment produce similar
outcomes. [38] Further research will be needed to clarify what factors influence the success of
MBT, as well as to explicate its mechanisms of action.

Schema Therapy (ST). Originally known as Schema-Focused Therapy, this treatment was
developed by Jeffrey Young as a form of cognitive therapy. ST sees BPD as stemming from a
characteristic set of stereotypical “schema modes,” or patterns of thinking, feeling, and behaving
with early developmental roots. BPD is thought to involve four or five of these modes, including
the Angry and Impulsive Child, the Abused and Abandoned Child, the Detached Protector, the
Punitive Parent, and (sometimes) the Healthy Adult. [39–41] The patient shifts abruptly among
these different schemas, leading to the chaotic clinical picture. ST therapist’s aim is to facilitate
the substitution of these maladaptive schemas with healthier ones, between which the individual
can shift gradually based on the realistic demands of his or her environment. To this end, ST
utilizes cognitive, experiential, and behavioral interventions and focuses heavily on the provision
of a strong, quasi-parental relationship between patient and therapist. [39]
ST has shown efficacy in one RCT comparing three years of ST to three years of
Transference-Focused Psychotherapy (TFP; see below). The ST group had less dropout and
better clinical outcomes than the TFP group. [42] Other randomized trials have examined groupbased ST in comparison to treatment as usual and have suggested that therapist after-hours
telephone availability is not necessary for improvement in ST. [43,44] More recently, outcome
studies have examined combinations of individual and group ST [45] and community
implementations of ST. [46]
Transference-Focused Psychotherapy (TFP). TFP is based on the modified
psychoanalytic treatment framework by Otto Kernberg, which in turn is based on Kernberg’s
seminal description of borderline personality.[47] Like ST, TFP is organized around the theory
that the core deficit in BPD is the individual’s disordered and incoherent mental representations
of self and others. These representations are thought to be “split,” or organized into all-positive

and all-negative parts, which makes it difficult for the patient to regulate their emotions and
behaviors effectively, especially in an interpersonal context. [48] A TFP therapist intervenes to
modify these representations, chiefly by using events in the therapeutic relationship to observe
and explore them, to point out conflicting elements of the patient’s views of self or others, and to
suggest alternative, more realistic views. Thus, unlike classical psychoanalysis, TFP restricts
attention to the “here-and-now,” and the therapist takes a very active stance. Like DBT, TFP
proceeds within a strong treatment frame, with a clear delineation of patient and therapist
responsibilities; patients are required to pursue meaningful activity (e.g., employment), to
maintain sobriety, and to participate fully in treatment sessions. This frame is meant not only to
create a secure context for the patient to engage in the difficult process of change, but also allows
the therapist to interpret deviations from this contract on the patient’s part through the lens of the
therapeutic relationship.
TFP has shown evidence of efficacy in two RCT’s. In one, TFP was compared to DBT
and to supportive psychotherapy, showing effects on several outcome domains that were similar
(or perhaps superior) to these control treatments. [49] In a second RCT, patients receiving TFP
showed better outcomes on most BPD-relevant variables than patients receiving psychotherapy
in the community. [50] However, in a third RCT comparing three years of TFP to three years to
Schema Therapy (described above), the TFP group did not fare as well as the ST group, in part
because of higher rates of dropout in TFP. [42] Nevertheless, the low therapist competence
ratings in the TFP arm raise questions as to how faithfully TFP was delivered in this trial – an
noteworthy limitation, as conformity to TFP technique is an important predictor of outcome. [51]
More recent studies have explored mechanisms of change within TFP and identified neural
correlates of the symptom changes brought about by the treatment. [52,53]

Adjunctive Treatments
In addition to the stand-alone, specialty treatments above, several interventions have been
designed as adjuncts to other treatments. Systems Training for Emotional Predictability and
Problem Solving (STEPPS) is one such intervention. [54] Like DBT, STEPPS is based in
cognitive-behavioral principles, considers extreme emotional experience to be a core
characteristic of BPD, and utilizes group-based skills training. Unlike DBT, however, STEPPS
also focuses heavily on family systems and psychoeducation, two types of interventions that are
only incidental to DBT. STEPPS plus treatment-as-usual has shown promising evidence of
efficacy in comparison to treatment-as-usual in randomized controlled trials, [55,56] and there is
also promising evidence that STEPPS can be implemented effectively in traditional treatment
settings. [57] Recent evidence suggests, however, that DBT may be somewhat better than
STEPPS when it comes to treating overall borderline symptoms. [58]
A second adjunctive intervention that shows promise in the treatment of BPD is the
motive-oriented therapeutic relationship (MOTR). This is not a treatment in its own right but
instead a structured method for managing how the patient’s pathology manifests within the
relationship with the therapist. Use of the MOTR is intended to obviate the patient’s need to
enact problematic interpersonal behaviors by identifying and meeting the needs these behaviors
serve. [59] A randomized trial comparing brief Good Psychiatric Management (GPM; see below)
with GPM plus MOTR suggested that MOTR yielded additional gains in interpersonal outcomes
and biased thinking, although reduction in borderline symptoms was similar for both groups.
[60–62]
Pragmatic and Psychoeducative Treatments

In addition to the adjunctive treatment options above, there exist a number of pragmatic
interventions designed to be used by trainees (e.g., psychiatry residents), case managers, and
other support specialists. The most prominent of these pragmatic interventions was once called
“General Psychiatric Management” and is now called Good Psychiatric Management (GPM).
GPM is a case-management approach based on psychiatric practice guidelines, focusing on
psychoeducation but also including supportive-psychodynamic and cognitive-behavioral
psychotherapeutic elements. [63,64] The treatment was developed by John Gunderson and
manualized [63] to serve as the control treatment for DBT in a randomized trial. [16] Notably,
this trial is the largest RCT attempted to date, and the authors found no outcome differences
between DBT and GPM, nor have any emerged at follow-up. [65] Since these early
developments, GPM has continued to be used as a comparison group for more specific BPD
treatments, and the encouraging results have prompted calls for GPM to be used as a first-line
generalist treatment for the disorder. [66,67]
Finally, Mary Zanarini and colleagues have shown, in two separate trials, that mere
psychoeducation about BPD (i.e., its clinical characteristics, course, and etiology and available
treatment options) is better than a no-treatment control, at least on some outcomes. [68,69] The
superiority of this minimal intervention – in the second trial, delivered via the Internet – may
speak to the degree to which ignoring the BPD diagnosis, or not sharing it with patients to whom
it applies, can be harmful, or at least a missed opportunity. Nevertheless, these studies do not
compare psychoeducation to active treatment comparison conditions, and so it remains to be seen
whether a well-delivered therapy would be preferable to psychoeducation.
Does the Kind of Treatment Make a Difference?

Given the plurality, and the diversity, of evidence-based psychotherapeutic treatment
options for BPD, it is scientifically and clinically important to consider the question of whether
these different psychotherapies work equally well. This is indeed a complex question.
Randomized controlled trials are undoubtedly the most straightforward way to resolve it, and yet
there have not been enough head-to-head comparisons of these treatments to provide a definitive
answer. The extant controlled studies are also extremely varied in terms of treatment dose,
setting, choice of control group, and other design and sample characteristics, which may
contribute to the large heterogeneity in effect size among these trials identified by a recent metaanalysis. [10••] Nonetheless, there is little doubt that the specialized treatments for BPD outlined
above are more effective, on average, than treatment-as-usual or generic psychological or
psychiatric care, which on its own shows only small effects. [70•] These bona fide therapies
should be considered the preferred treatments for BPD based on the available evidence.
Taken together, head-to-head trials (see Table) do not generally suggest superiority of
any of the available specialized treatments for BPD relative to one another, despite the results of
some individual studies suggesting otherwise. In addition, although these treatments operate on
different theories of BPD and focus on different symptoms of the disorder, none of them is
uniquely effective in bringing about improvement on the outcome domains they target. Specific
treatment effects are the exception and not the rule. For instance, TFP improves attachment and
mentalization, despite the fact that it does not explicitly work to do this, unlike MBT. [71,72]
Similarly, DBT, not just TFP, shows favorable outcomes for self-concept coherence and
defensive functioning. [33,73,74] Even though some studies show differences between
treatments in rates of improvement for different symptoms, these effects are inconsistent from
trial to trial and sometimes from one measurement to another. For instance, a recent non-

randomized trial found that DBT led to faster reductions in self-harm than MBT, but by the end
of the study both treatments had achieved the same degree of reduction in this symptom. [33]
As others have pointed out, the specialized, evidence-based psychotherapies for BPD
named above – DBT, MBT, ST, and TFP – also have several elements in common. [63,75–77]
First, they all explicate a coherent model of the disorder within the therapy (despite the lack of
agreement among treatments about these models themselves). Second, they work within a strong
treatment frame, which may be necessary to enable the patient to do the difficult work of
changing his or her behavior. Third, nearly all the treatments are long-term, lasting at least 6
months. This characteristic may not be strictly necessary, as shorter treatments can also be
effective, especially at reducing acute symptoms. Randomized trials contrasting long-term and
short-term versions of both DBT and MBT are also underway. [78,79] Fourth, these treatments
have a strong focus on the here-and-now rather than on past relationships. Indeed, many
treatments (such as SFT, TFP, and MBT) use the therapeutic relationship itself to help the patient
develop more adaptive patterns of relating to others. Finally, each bona fide treatment for BPD
offers interpersonal continuity in the form of a stable, reliable relationship with a therapist,
treatment team, and/or therapeutic milieu. The importance of continuity of care for BPD
outcome should not be overlooked; a fascinating study by Bales and colleagues suggests that
organizational disruptions may affect the outcome of MBT, for instance. [80•] In sum, it is clear
that certain specialized psychotherapies for BPD offer an advantage over general community
treatment. In that respect, the type of treatment does make a difference. There is little compelling
and consistent evidence, however, that any of these dedicated therapies is superior to any of the
others, even in treating the specific outcome domains that they attempt to address, and there are
many possibly important common factors among these treatments.

Psychotherapeutic Treatment for BPD: What We Still Don’t Know
Despite the overall evidence for the efficacy and effectiveness of existing
psychotherapeutic treatment options for BPD, there is still much to be discovered. For example,
it is not at all clear how to prescribe one of these treatments over another, when a choice is
available. No matter how consistent the results of a given therapy are for the “average individual
with BPD,” some patients show little benefit at all, and it is unknown whether these nonresponders would have benefited from an alternative treatment. Similarly, it is not clear whether
responders to one treatment would have done still better in another. [81] Intriguing initial results
on this score come from a recent re-analysis of the large RCT by McMain and colleagues
comparing DBT and GPM. [16] A cross-validated (but within-sample) procedure to identify
moderators of differential response to these treatments suggested that patients with higher
severity and impulsivity benefited more from GPM, whereas those with more dependent
personality traits, childhood emotional abuse, social maladjustment, and higher depression
severity did better in DBT. [82••] If these results are validated independently, they may point to
the potential to select optimal treatments for this extremely heterogeneous disorder.
We also have little idea how long treatment effects within any of these therapies last
beyond the short term. The longest follow-up assessments to date were 5 years after the
termination of therapy. [30] Given the often chronic course of BPD, with sustained impairment
and low functioning the norm even after symptomatic improvement, [83] this lack of knowledge
about long-term effects is particularly troublesome. Existing treatments for BPD may reliably
lead to symptom remission, but far less is known about how to facilitate sustained adaptive work
and relationship functioning. General functioning may improve, [18,32,36,43,49,50,84,85] but

many treated individuals are still underemployed and lack sufficient stable and meaningful
romantic and friend relationships at the end of treatment or at follow-up. [30,86]
Conclusions
In sum, there is solid evidence that various specific therapies (including DBT, MBT, ST,
and TFP) are superior to treatment as usual in the community for Borderline Personality
Disorder. There are also several adjunctive and minimal/pragmatic treatment options available
with research support. There is no reliable evidence that any of these treatments is more effective
than any other, however. In addition, existing treatments have many elements in common that
may be responsible in part for their effects. Future research will be needed to uncover how
patient characteristics and treatment parameters affect the outcome of these therapies.
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Table — Head to Head Comparisons between Evidence-Based Therapies for BPD
First author
Type
Treatment groups
Outcomes
Barnicot [33]
naturalistic DBT (n = 58)
No differences in clinical
MBT (n = 32)
outcomes at month 12
Feliu-Soler [87]
nonDBT mindfulness (n = 18) DBT-mindfulness group had
randomized GPM (n = 17)
better depression and
symptom scores at posttest;
no difference in emotional
reactivity
McMain [16]
RCT
DBT (n = 90)
No differences in outcomes;
GPM (n = 90)
similarity persists at followup
Kramer [59]
RCT
GPM + MOTR (n = 11)
MOTR group showed more
GPM (n = 14)
improvement in
interpersonal problems; no
other clinical differences
Edel [88]
nonDBT skills + MBT (n =
No differences in BPD
randomized 29)
symptoms or attachment;
DBT skills (n = 28)
mixed results on mentalizing
Kramer [60]
RCT
GPM + MOTR (n = 42)
MOTR group showed more
GPM (n = 43)
improvement in general
symptoms, but not BPD
symptoms or interpersonal
problems
Clarkin [49]
RCT
TFP (n = 23)
No differences in direct
DBT (n = 17)
comparison, although
treatments had varying
effects on outcomes pre-post
Giesen-Bloo [42]
RCT
ST (n = 45)
ST group showed more
TFP (n = 43)
change in BPD symptoms
and a composite measure of
secondary outcomes; no
differences in quality of life
Guillén Botella [58] nonDBT (n = 45)
DBT group showed more
randomized STEPPS (n = 27)
improvement in BPD
behavioral symptoms and
fear of suicide; no other
differences
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